Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722173 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket

<< Back to Search Results



Immunotoxicology Strategies for Pharmaceutical Safety Assessment
John Wiley and Sons Ltd, Sep 2008, Pages: 402


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

This book is an important reference which provides an overview of the current and recently introduced methodologies for testing the immunotoxic risks in drug candidates. It helps readers understand the significance of the methods and approaches to immunotoxicology testing. It can aid drug scientists in industry and regulatory areas to consolidate approaches to immunotox testing. It also offers a definitive assessment of nonclinical models to study the toxic impacts (bio)pharmaceuticals can have on the immune system. It Includes chapter authors from across the pharma industry, bringing a real-world and applied perspective to immunotox testing

Authors bio:
Danuta J. Herzyk, Phd, is the Senior Scientific Director in the Safety Assessment Department of Merck Research Laboratories. She previously worked in immunologic toxicology for GlaxoSmithKline. A member of the Society of Toxicology, Drug Information Association, and American Association of Immunologists, Dr. Herzyk has published over forty articles. She serves on the editorial board of Perspectives in Experimental and Clinical Immunotoxicology.

Jeanine L. Bussiere, Phd, is an Executive Director of Toxicology at Amgen. She is the author or coauthor of eight book chapters and approximately fifty articles. She is on the editorial board of Journal of Immunotoxicology. Dr. Bussiere is a member of the Society of Toxicology, American College of Toxicology, and Drug Information Association.

Product samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

Immunogenicity to Biologics

Molecular and Biochemical Toxicology, 4th Edition

Chromatographic Methods in Clinical Chemistry and Toxicology

Drug Testing In Vitro: Breakthroughs and Trends in Cell Culture Technology

Fundamentals of Analytical Toxicology

Computational Toxicology: Risk Assessment for Pharmaceutical and Environmental Chemicals

Toxicology and Risk Assessment: A Comprehensive Introduction

Pharmacogenomics for Clinical Use and in Drug Development

Immune Modulation Therapeutics

Clinical Laboratory Testing Volume 1: Reagents and Instruments

Cell Therapy - Technologies, Markets and Companies

Clinical Laboratory Testing Volume 2: Business Strategies



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds